RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma

Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies, and the incidence of RCC continues to rise worldwide. Although RCC can be treated with surgery at an early stages, the five-year survival rates have been observed to decline dramatically in patients with advanced disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Sifan, Dai, Jie, Ma, Meng, Xu, Tianxiao, Kong, Yan, Cui, Chuanliang, Chi, Zhihong, Si, Lu, Tang, Huan, Yang, Lu, Sheng, Xinan, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420644/
https://www.ncbi.nlm.nih.gov/pubmed/30874541
http://dx.doi.org/10.1038/s41419-019-1488-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420644/
https://www.ncbi.nlm.nih.gov/pubmed/30874541
http://dx.doi.org/10.1038/s41419-019-1488-2

Ejemplares similares